Clinical trials
Recruiting Atherosclerosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2018 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 7 |
| 2024 | 6 |
| 2025 | 9 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 4 |
| VA Office of Research and Development | 4 |
| Eli Lilly and Company | 3 |
| Massachusetts General Hospital | 3 |
| Amgen | 1 |
| AstraZeneca | 1 |
| Beijing Inno Medicine Co., Ltd. | 1 |
| Brigham and Women's Hospital | 1 |
| CSL Behring | 1 |
| Colorado Prevention Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 39 |
| Cardiovascular Diseases | 9 |
| Coronary Artery Disease | 7 |
| Peripheral Arterial Disease | 6 |
| Obesity | 4 |
| Genetic Risk Score | 3 |
| Hypercholesterolemia | 3 |
| Cardiomyopathies | 2 |
| Diabetes Mellitus | 2 |
| Diabetes Mellitus, Type 2 | 2 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.